Drs. Caleb Skipper, Mahsa Abassi and David Boulware collaborated with researchers from Makerere University, Uganda, to study a new oral formulation of a drug (amphotericin B) to treat cryptococcal meningitis. Results of the phase II randomized clinical trial were presented in an oral abstract at the IDWeek conference. READ MORE>>